, methadone and 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine from urine samples. Samples were extracted by solid-phase extraction (SPE) with cation exchange cartridges using a TECAN Freedom Evo 100 base robotic system, including a hydrolysis step previous extraction when required. Block modules were carefully selected in order to use the same consumable material as in manual procedures to reduce cost and/or manual sample transfers. Moreover, the present configuration included pressure monitoring pipetting increasing pipetting accuracy and detecting sampling errors. The compounds were then separated in a chromatographic run of 9 min using a BEH Phenyl analytical column on a ultra-performance liquid chromatography -tandem mass spectrometry system. Optimization of the SPE was performed with different wash conditions and elution solvents. Intra-and inter-day relative standard deviations (RSDs) were within + + + + +15% and bias was within + + + + +15% for most of the compounds. Recovery was >69% (RSD < 11%) and matrix effects ranged from 1 to 26% when compensated with the internal standard. The limits of quantification ranged from 3 to 25 ng/mL depending on the compound. No crosscontamination in the automated SPE system was observed. The extracted samples were stable for 72 h in the autosampler (48 8 8 8 8C). This method was applied to authentic samples (from forensic and toxicology cases) and to proficiency testing schemes containing cocaine, heroin, buprenorphine and methadone, offering fast and reliable results. Automation resulted in improved precision and accuracy, and a minimum operator intervention, leading to safer sample handling and less time-consuming procedures.
Introduction
Ultra-performance liquid chromatography -tandem mass spectrometry (UHPLC-MS-MS) provides forensic and clinical laboratories with a powerful tool for fast, robust, accurate and sensitive detection of a wide variety of analytes (1, 2) . However, biological samples are usually not directly compatible with UHPLC -MS-MS analyses. An efficient sample treatment is required to achieve a good analytical result (1, 3, 4 ). An ideal sample preparation method should be selective, accurate, fast, cheap and safe. However, associated manual operations for sample clean-up are usually very labor intensive, time consuming and susceptible to human errors at many stages. Moreover, large solvent consumption can be an issue (2, 5 -11) . Therefore, in order to increase efficiency of routine analysis, laboratory automation is an increasingly popular concept in the modern day laboratory. Much of this recent growth stems from increased capabilities of commercially available workstations. Typically, liquid transfer steps, including the addition of the internal standard (IS), quality control (QC) and samples may be performed automatically (12 -15) . Clinical and forensic laboratories are subjected to meet high levels of quality. Automation could also be an interesting choice to improve the quality of laboratory performance. Automation of offline solid-phase extraction (SPE) is possible and the utility of '96-well SPE' was introduced some years ago. Nowadays, an attractive approach is also the on-line SPE where the entire process takes place at constant flow rates, no manual transfers are made and the whole eluate is loaded onto the LC column without the need of a pre-concentration step (7, 10, 11) . However, some restrictions should be considered, such as sample instability, and less flexibility than with offline SPE techniques. Contamination between samples may also be an issue in on-line SPE procedures.
Consequently, the aim of this study was to develop a sample preparation setup that could handle forensic material in an automated procedure and which could satisfy the following criteria: reduce human intervention time; avoid human errors; be integrated with laboratory information management system (LIMS); be flexible to meet changing needs; produce no sample crosscontamination; and monitor samples and extraction steps.
The TECAN Freedom Evo series offers different worktable capacities with building-block modularity. Each platform can be combined with robotic arms, liquid-handling tools and application options powered by straightforward software. To date, just a few papers using this robotic system have already been published concerning applications of drug analysis in biofluids (12 -17) . Andersen et al. (16) reported a validated robotic setup for pipetting the IS and blood samples to quantify tetrahydrocannabinol (THC). Pipetting of low volumes (6 mL) with high accuracy was observed. Bjork et al. (17) has recently published an interesting validated method for the analysis of 31 illicit and medicinal drugs (including some benzodiazepines, opioids, opiates, amphetamines and other stimulants) in blood using the TECAN robot. In this configuration, automated SPE using 96-well plates, a vacuum station and an integrated balance (to correct for the concentration) were used and the samples were analyzed with UHPLC -MS-MS.
The opioids are a large group of drugs which are medically used to relieve pain but also have a high potential for abuse. The presence of 6-monoacetyl-morphine (6-MAM) in biological samples indicates prior use of heroin and enables differentiation between morphine and heroin-related deaths. Cocaine is also a popular drug which can be consumed in combination with heroin or other opioids such as fentanyl. Therefore, determination of these compounds in biological specimens is often performed by clinical and forensic laboratories. Some papers have already been published concerning the analysis of opioids in biological samples with automated sample cleanup procedures describing the detection of one single compound or a mixture of a few opioids (6, 14, (17) (18) (19) .
The objective of the present study was the automation and the optimization of an SPE procedure for the analysis of 23 compounds including morphine, hydromorphone, oxymorphone, norcodeine, codeine, dihydrocodeine, oxycodone, 6-MAM, hydrocodone, ethylmorphine, benzoylecgonine, cocaine, cocaethylene, tramadol, meperidine, pentazocine, fentanyl, norfentanyl, buprenorphine, norbuprenorphine, propoxyphene, methadone and 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) in 100 mL of urine using the TECAN Freedom Evo 100 base system (TECAN, Mechelen, Belgium) and in a single run.
This system was used to automate the hydrolysis step and the sample preparation, starting from the original urine tube to end in the vial to be analyzed in the UHPLC-MS-MS system, ensuring sample integrity. The method was validated in terms of selectivity, accuracy, precision, stability, recovery and matrix effects for non-hydrolyzed urine samples. Hydrolysis was not routinely carried out, because it may degrade 6-MAM, which presence was considered by the authors of significant importance for the interpretation of each case. As 6-MAM may be degraded by the b-glucuronidase, hydrolysis was carried out just for specific cases.
Experimental
Chemical and reagents Individual certified reference standard solutions of morphine, codeine, hydromorphone, hydrocodone, norcodeine, oxycodone, oxymorphone, ethylmorphine, meperidine, pentazocine, propoxyphene, dihydrocodeine, 6-MAM, methadone, EDDP, cocaine, benzoylecgonine, cocaethylene, fentanyl, norfentanyl, tramadol (1 mg/mL), buprenorphine and norbuprenorphine (0.1 mg/mL), and their ISs morphine-d 3 
buprenorphine-d 4 and 6-MAM-d 6 (0.1 mg/mL) were obtained from LGC Standards (Molsheim, France). Water (HPLC grade), methanol (UPLC -MS grade) and 0.1% formic acid in water (UPLC -MS grade) were purchased from Biosolve (Valskenswaard, The Netherlands). Hydrochloric acid 0.1 N, dichloromethane, 2-propanol, ammonia, formic acid, bglucuronidase from Helix Pomatia, hydrochloric acid (37%) and ammonium formate ( powder) were purchased from VWR (Leuven, Belgium). Oasis MCX cartridges (60 mg, 3 cc) were obtained from Waters (Zellik, Belgium).
Pooled blank urine samples were used for development and validation of the procedure and were obtained from healthy volunteers. A negative urine control was purchased from Biorad Laboratories (Cardiff, UK). Authentic samples were obtained from forensic toxicology cases.
Preparation of standard solutions
Separate working solutions of the drugs for tuning and selectivity experiments were prepared in the laboratory at a concentration of 4 mg/L in methanol. A mixed working solution of nondeuterated compounds in acetonitrile was used for the preparation of calibrators. The concentration was 4 mg/L for morphine, oxymorphone, norcodeine, codeine, dihydrocodeine, ethylmorphine, benzoylecgonine, tramadol, meperidine, cocaine, pentazocine, cocaethylene, EDDP, propoxyphene and methadone (Group 1), and 0.8 mg/L for fentanyl, norfentanyl, buprenorphine, hydromorphone, oxycodone, hydrocodone, norbuprenorphine and 6-MAM (Group 2). A mixed IS working solution of 0.4 mg/L for the deuterated standards (0.08 mg/L for fentanyl-d 5 , buprenorphine-d 4 and 6-MAM-d 6 ) was also prepared in acetonitrile. All working solutions were stored at 48C. To obtain the lower concentrations needed for internal standardization and validation of each experiment, further dilutions in sodium acetate buffer 0.1 M ( pH 4) for non-hydrolyzed urines and, in sodium acetate buffer 3M ( pH 4.6) for the hydrolysis experiments, were prepared the same day. The external QCs were prepared following the instructions of the manufacturer.
Apparatus
Instrumentation for sample preparation Sample preparation was automatically performed on a TECAN Freedom Evo 100 base robotic platform (TECAN) with several add-ons from TECAN and third-party vendors ( Figure 1 ): a TECAN liquid-handling arm with eight independent channels (four using disposable filter tips and four with fixed needles) and pressure monitoring pipetting (PMP), a 'pick&place' (P&P) robot arm for sample movements, an SPE manifold (including a module for 32 SPE cartridges (3 mL, 60 mg) and a module for the direct elution into the 32 LC vials (Waters)), a shaker vortexer, a plate support, carriers for urine tubes, a water bath Figure 1 . Schematic representation showing the individual equipment and modules incorporated into the automated system: (1) 1,000 mL disposable tips; (2) 200 mL disposable tips; (3) tips waste; (4) solvents waste and wash station; (5) water bath for incubation used also as urine sample carrier when switched off; (6) IS carrier; (7) reconstitution buffer (ammonium formate buffer 0.05 mM (0.05% formic acid); (8) sample tubes carrier where the last four positions were for the elution solvent; (9) vials; (10) SPE station with the SPE cartridge module; (11) tube gripper downholder, (12) plate support (for caps), (13) shaker vortexer; (14) liquid handling arm with eight independent pipetting channels (four of them for the disposable filter tips), (15) a robot manipulator arm for sample movements 'P&P; (16) 1D/2D barcode scanner and (17) b-glucuronidase enzyme carrier.
used for incubation or as a carrier (when switched off) for sample tubes, carriers for solvents, 1D/2D barcode scanner, tube gripper downholder, five independent solvents lines and one line for the system liquid. All modules were programmed and controlled with Tecan Evoware 2.3 SP3.
Urine tubes (greiner bio-one VWR) were placed into the carriers and the corresponding method was applied: first, the barcode of the urine tube was compared with a sample list created by the LIMS. Then, the caps of the urine tubes were removed and 100 mL of each urine sample was added to the sample tubes (greiner bio-one), followed by 100 mL of the IS dilution.
When the hydrolysis was carried out, 25 mL of b-glucuronidase from Helix pomatia was added to the sample tubes, vortexmixed and then incubated at 378C (overnight, 16 h). As it was carried overnight, it did not disturb the routine work in the laboratory.
Then, the TECAN system added 675 mL of water (for hydrolyzed sample experiments) or 675 mL sodium acetate buffer 0.1 M ( pH 4) to the sample tubes and vortex-mixed. The samples tubes were then recapped. After conditioning the Oasis MCX cartridges with 1 mL of methanol and 1 mL of sodium acetate buffer 0.1 M ( pH 4) applying 3 mL of air between the solvents, the diluted samples were applied to the SPE columns with disposable tips. Cleanup was accomplished with successive 0.8 mL washes of 0.1 N hydrochloric acid, and 4 times 0.8 mL methanol, applying 5 mL of air between washes. Then the cartridges were eluted with 1.5 mL of dichloromethane: 2-propanol: ammonia (80:18:2, v/v/v) directly into LC vials. The vials were evaporated to dryness in a vacuum centrifuge (Analis, Namur, Belgium) and placed again into the Tecan system. The robot added 1 mL of ammonium formate buffer 5 mM (0.05% formic acid) and the vials were all automatically capped and vortex-mixed.
Ultra-performance liquid chromatography-tandem mass spectrometry
Chromatographic conditions UHPLC was performed using an UPLC separation module (Waters, Milford, MA, USA). Analytes were separated using an Acquity UPLC BEH Phenyl (2.1 Â 100 mm, 1.7 mm) (Waters). The column was kept at 508C. A gradient elution using two solvents, A and B, were used. Solvent A consisted of water containing 0.1% formic acid. Solvent B was methanol (0.1% formic acid). The gradient was carried out starting from 5% B for 1.5 min and then to be increased to 25% B over the next 2.5 min. At 4 min B was increased linearly to 50% for 3 min. At 7.5 min B was set to 95% for 1.5 min, resulting in a total run time of 9 min. The weak needle wash was 2.5 mL of methanol:water (10:90, v/v) and the strong needle wash was 0.6 mL of methanol:acetonitrile:isopropanol:water:formic acid (25:25:25:24.9:0.1, v/v/v/v/v). After the injection of each sample, three reconstitution buffer injections were carried out to prevent carryover in the UHPLC system: the first two injections with an isocratic run of 0.5 min at 5:95 (A:B) and the third run at 95:5 (A:B) for 2 min, leading to a complete run time (between samples) of about 12 min. The mobilephase flow was set to 0.35 mL/min.
Tandem MS
A Quattro Premier tandem mass spectrometer (Waters) was used. Ionization was achieved using electrospray in positive ionization mode (ESIþ). Nitrogen was applied as nebulization and desolvation gas at a flow rate of 900 L/h and heated to 3508C. Capillary voltage and source block temperature were 1 kV and 1208C, respectively.
In order to establish the appropriate multiple reaction monitoring (MRM) conditions for the individual compounds, solutions of standards (200 ng/mL, in mobile phase) were infused into the mass spectrometer and the cone voltage (CV) was optimized to maximize the intensity of the protonated molecular
þ . Collision-induced dissociation of each protonated molecule was performed. The collision gas (argon) pressure was maintained at 0.35 Pa (3.5 Â 10 23 mBar) and the collision energy (eV) adjusted to optimize the signal for the most abundant product ions, which were subsequently used for MRM analysis (Table I) .
Methods

UHPLC-MS-MS assay validation
Selectivity and specificity The selectivity and specificity of the method against endogenous interferences was verified by examination of the chromatograms obtained after the extraction of eight different blank urine samples from healthy volunteers spiked with the IS and another eight not spiked with the IS. Authentic urine samples from cannabis, amphetamines and benzodiazepines users were also analyzed. In addition, analysis of each compound spiked alone (at 500 ng/mL) in mobile phase was evaluated.
Linearity, limit of quantification, precision and bias Quantification was performed by integration of the area under the specific MRM chromatograms in reference to the integrated area of the deuterated analog. Freshly prepared working solutions in 0.1 M sodium acetate buffer ( pH 4) were used to prepare urine calibrators at a concentration of 750, 500, 250, 125, 75, 50, 25 and 15 ng/mL for Group 1, and at concentrations of 150, 100, 50, 25, 15, 10, 5 and 3 ng/mL for Group 2. Standard curves, freshly prepared with each batch of QC samples and authentic samples, were generated using a least-squares linear or quadratic regression (depending on the compound), with a 1/x-weighting factor for all compounds.
The limit of quantification (LOQ) was evaluated by replicate analysis (n ¼ 2) over eight different days and accepted if the fixed concentration at which it was calculated was within +20% of the nominal value and with a relative standard deviation (RSD) ,20%.
Two external QCs and two internal QCs were analyzed within each batch. External QCs for urine samples were obtained from Medichem World (Steinenbronn, Germany): Medidrug U-confirmation cutoff þ25% and Medidrug U-confirmation cut-off 225%.
Intra-assay and inter-assay imprecision were evaluated by replicate (n ¼ 2) analysis of the QC samples performed over eight different days. Imprecision (expressed as %RSD r for intra-assay imprecision and %RSD t for inter-assay imprecision) was determined by performing the analysis of variance: a 'single factor' ANOVA test (significance level (a) of 0.05). Bias of the method was determined by comparison of the mean of calculated concentrations of QC samples to their respective nominal values.
Stability
Stability of processed samples kept in the autosampler at concentrations of 30 and 600 ng/mL for Group 1 and at concentrations of 6 and 125 ng/mL for Group 2 was monitored as follows: six samples (at each concentration level) were determined immediately and re-analyzed after remaining in the autosampler at 6 + 28C for 72 h.
Stability of compounds in the matrix was determined through spiked blank urine samples with concentrations of 30 and 600 ng/mL for Group 1 and at concentrations of 6 and 125 ng/mL for Group 2 (n ¼ 6 at each concentration). Stability was checked after three freeze -thaw cycles.
All the stability experiments were tested against a lower percentage limit corresponding to 85 -115% of the ratio (the mean value of stability samples/mean value control samples) with a 90% of the confidence interval of the stability samples between 80 and 120% of the mean of the control samples.
Assessment of matrix effects
To assess any potential suppression or enhancement of ionization due to the sample matrix, a matrix effect experiment was carried out. It consisted of a comparison between the peak absolute areas and the responses of the compounds manually spiked to a blank urine sample after the automated SPE extraction with those obtained after manually spiking the mobile phase at the same concentrations.
Concentrations were 30 and 600 ng/mL for Group 1 and at concentrations of 6 and 125 ng/mL for Group 2 (n ¼ 8 at each concentration).
Solid-phase extraction recovery
Extraction recoveries were estimated by comparing the ratio of the peak areas of the non-deuterated compounds to the peak areas of the IS (i.e., responses) of blank urine samples manually spiked at 30 and 600 ng/mL for Group 1 and at concentrations of 6 and 125 ng/mL for Group 2 (n ¼ 8 for each concentration), when the non-deuterated compounds were manually added before the automated extraction step with those obtained when the nondeuterated analytes were added after automated sample extraction. In both cases, the deuterated analogs were manually added after the extraction.
Cross-contamination in the TECAN Freedom Evo 100 base system Carryover was evaluated by the extraction of blank urine samples (n ¼ 3) spiked with the IS after the extraction of blank urine samples (n ¼ 3) spiked at 7,500 ng/mL for Group 1 and at concentrations of 1,500 ng/mL for Group 2. Blank urine samples were also extracted after authentic samples to check for contamination.
Carryover in the UHPLC-MS-MS system
Blank urine samples spiked with the IS (n ¼ 3) were analyzed after the analysis of three urine samples spiked with 10 times a concentration higher than the upper limit of quantification (n ¼ 3).
Results and discussion
The development of an appropriate automated biological sample preparation technique is not always straight-forward and highly dependent of choices made in the instrument configuration. Underlined transition was used for quantification.
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The TECAN Freedom Evo 100 base system setup was decided by requirements of the laboratory. The TECAN liquid handling arm was fitted with four independent PMP channels with disposable tips and 1 mL syringes. Thus, a lack of contact between samples and manifold was assured, avoiding cross-contamination and excessive washing of needles. Other advantages of PMP are that it identifies pipetting errors (clogging, aspiration of air, system leakage and clots), it increases pipetting accuracy (RSD for 10 mL is ,2.5%) and no concentration correction is required. Moreover, it works with positive pressure which allows a higher control during the SPE procedure (e.g., flow rate) than a vacuum station as each sample is controlled independently. In case of an irregularity, the sample is flagged by the software. The block modules were carefully selected in order to use the same consumable material as in manual procedures already applied in the laboratory (20) to reduce cost and manual sample transfers. It should be flexible enough to 'scale down' the SPE procedure if desired in the near future. This TECAN workspace configuration can hold carriers for different laboratory recipients and the SPE module is designed to hold different SPE cartridge volumes. Thirty-two samples may be analyzed within each batch in 4 h, which is acceptable for forensic laboratories. Furthermore, the TECAN system is equipped with a barcode reader assuring sample integrity. The use of barcodes allows the software to use work lists generated by a LIMS to 'force' a certain order in the SPE sequence. Compared with manual methods, there was a significant reduction of human intervention time and human errors (e.g., switching samples, forgetting to add a solvent, IS, etc.).
Optimization of the sample clean-up procedure was necessary in order to obtain the best compromise between recovery, matrix effect, accuracy and precision for the 23 compounds of interest. During a preliminary validation, different SPE conditions were evaluated by comparing matrix effect, extraction efficiency and linearity (r 2 ) data. Detailed data are not shown; however, the authors want to highlight the importance of selection of appropriate conditions with the following comments. First, Oasis MCX (Waters) and Strata-X Cation exchange cartridges (Phenomenex, Utrecht, The Netherlands) were compared. No significant Intra-assay, inter-assay precision and bias were evaluated by replicate (n ¼ 2) analysis of the QC samples performed over eight different days.
differences were observed (RSD , 20%). Oasis MCX was then selected because it was already used in manual SPE procedures for other routine accredited analysis (20) . Secondly, during the loading and washing steps the volume of aqueous solutions and air passing the SPE were carefully adapted. If high volumes of aqueous solvents were loaded or if the cartridges were not dry enough after each step, the following solvent overloads the cartridge and immiscibility of phases occurs. Third, the following elution solvents were evaluated (using 1 or 1.5 mL): methanol/ ammonia (95/5, v/v)), acetonitrile/ammonia (95/5, v/v) and dichloromethane/isopropanol/ammonia (80/18/2, v/v/v). One and a half milliliters of elution solvent was necessary to achieve acceptable results and no significant difference was observed (RSD , 20%) between the three elution solvents evaluated. Dichloromethane/isopropanol/ammonia (80/19/2, v/v/v) was chosen because of the shorter time for evaporation. Finally, the evaporation process after elution was performed using a vacuum centrifuge and not in the TECAN system, to reduce time and guarantee analyte stability. The present TECAN configuration can use nitrogen to evaporate the samples via the four fixed tips. To evaporate four samples at each time it would take about 15 min (for 32 samples would then require in total 2 h), while with the vacuum centrifuge would take about 15 min for the 32 samples. Moreover, 6-MAM and cocaine present instability at high pH conditions. Therefore, the use of the vacuum centrifuge (already available in the laboratory) was a better option. This sample manual transfer did not compromise the sample integrity because the samples were already eluted in the LC vials. The method was then validated for selectivity, linearity, LOQ, imprecision, bias, analyte and process sample stability, matrix effects, recovery and carryover for nonhydrolyzed samples according to international guidelines (21) . The method was then applied to the analysis of authentic samples. Thus, in general, urine specimen was not hydrolyzed. The sample hydrolysis step was only included in the automated method for specific forensic cases (because of the relevance of quantification of 6-MAM).
The applied chromatographic method ensured the elution of all the compounds within 9 min and produced peaks of acceptable symmetry. Selectivity of the method was achieved by a combination of retention time, precursor and two product ions (Table I) . For the corresponding deuterated analog only one transition was monitored. Figure 2 shows the MRM chromatograms obtained following the analysis of a control sample containing 15 or 3 ng/mL (depending on the compound), which corresponds to the LOQ. No interferences were observed after the analysis of blank urine samples and the blank urine spiked with other drugs, ensuring the selectivity of the method. During the analysis of each compound separately, a small response was observed for cocaethylene when cocaine was injected alone. According to the manufacturer, cocaethylene was an impurity in the certified reference standard of cocaine.
Calibration curves ranged from 15 to 750 ng/mL for Group 1 and at concentrations of 3 to 150 ng/mL for Group 2 (Table II) . Correlation coefficients of the weighed (1/x) linear or quadratic regressions for this range were higher than r 2 ¼ 0.99. The LOQ was fixed at 15 ng/mL for Group 1 and a LOQ of 3 ng/mL for Group 2, and with RSD , 20% for all the compounds.
The intra-and inter-assay imprecision were satisfactory, with all RSDs ,15% for all the compounds (Table III) . The results indicated that the bias of the assay was ,15% (except for codeine and methadone which was ,21%) ( Table III) .
Stability of the processed samples in the autosampler was monitored after 72 h (at 2-68C). No instability was observed during this period of time for all the compounds. Moreover, the compounds spiked to blank urine samples were also stable after the QC low and QC high are 30 and 600 ng/mL, respectively, for all the compounds except for fentanyl, hydromorphone, oxycodone, hydrocodone, norfentanyl, 6-MAM, buprenorphine, and norbuprenorphine (concentrations at 6 and 125 ng/mL).
three freeze -thaw cycles except for buprenorphine, norbuprenorphine, 6-MAM and pentazocine (at low concentrations presented a CV , 21%) but this did not compromise the quantification in routine analysis. Net matrix effect was observed for buprenorphine, norbuprenorphine, hydromorphone, methadone, EDDP, fentanyl, pentazocine and propoxyphene (,33%, RSD , 23%) (Table IV) ; however it was compensated with the IS for most of the compounds (matrix effect responses ,26%, RSD , 16%). The results of the extraction recovery study are presented in Table V . Acceptable and reproducible recoveries (.69% and RSD , 10%) were obtained with this SPE procedure for all analytes.
No sample cross-contamination was observed during the extraction process in the TECAN. For the UHPLC -MS-MS system, the short analysis of reconstitution buffer between samples lead to reduction of carryover to ,20% of the LOQ for all the compounds. If the three blank mobile-phase injections (total analysis time of 2.5 min, including reconditioning of the column) were not carried out between samples, carryover .20% of the LOQ was observed for benzoylecgonine, methadone and EDDP.
Samples from proficiency testing schemes (LGC Standards and GTFCH) have been analyzed with the present method containing morphine, 6-MAM, cocaine, benzoylecgonine, dihydrocodeine, methadone, EDDP, buprenorphine and norbuprenorphine, resulting in z scores ,0.71. Table VI shows the detailed results obtained from two proficiency testing schemes. Sample A was prepared from pooled urine provided by in-patients who had been admitted for the treatment of drug misuse; it is known to contain cannabinoids, benzodiazepines, heroin, methadone and possibly dihydrocodeine. This donor urine had been supplemented with donor drug free urine and the resulting urine was spiked by the addition of buprenorphine (8.0 ng/mL), methadone (600 ng/mL), benzoylecgonine (600 ng/mL) and THC -COOH (100 ng/mL). Sample B was prepared by diluting Sample A with drug free urine as a 10 times dilution. Sample C was a spiked blank urine sample containing buprenorphine, methadone and their metabolites.
The method was also applied to the analysis of authentic urine samples from opioid and cocaine users.
Conclusions
To our knowledge, this is the first automated SPE method using the TECAN Freedom Evo 100 base liquid handling system in combination with UHPLC-MS-MS detection for the selective analysis of 23 opioids, cocaine and metabolites in urine. The method was evaluated using two external QCs and two 'in house' QCs, and it was validated for selectivity, linearity, precision, accuracy, stability of the processed samples, stability of the analytes in urine after three freeze-thaw cycles, recovery, matrix effect and carryover. The method was successfully applied to the analysis of proficiency testing samples. It is currently used on a routine basis for quantitative determination of opioids, cocaine and metabolites in urine in forensic toxicology cases. Block modules used the same consumable material as in manual procedures and it included PMP, increasing pipetting accuracy and detecting sampling errors. It reduces the amount of time for sample preparation by 80% compared with a manual procedure (e.g., other manual tasks can be done in parallel), eliminating extraction QC low and QC high are30 and 600 ng/mL, respectively, for all the compounds except for fentanyl, hydromorphone, oxycodone, hydrocodone, norfentanyl, 6-MAM, buprenorphine, and norbuprenorphine (concentrations at 6 and 125 ng/mL).
time constraints and direct contact between the technician and the specimens. This study can be of interest to accredited laboratories and/or those working in an ISO 17025 environment.
